Cytomx Therapeutics
Clinical trials sponsored by Cytomx Therapeutics, explained in plain language.
-
New drug trial hopes to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug called CX-2051 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. About 160 adults will take part, and the drug may be given alone or with anot…
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control Recruiting nowThis early study tests a new drug called CX-801, alone or with another drug (pembrolizumab), in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. About 121 people will take part.
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC